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Abstract 
 
Neurosteroids have been identified in the 1981. Dehydroepiandrosterone sulphate (DHEAS) is one of the vital neurosteroids that de novo 
synthesized in the nervous system from cholesterol precursor (Baulieu & Robel, 1998). The aim of the study is to develop a method for 
fluorescence labelling. Alexa Fluor 488 dye with DHEAS antibody can binds the DHEAS antibody in the rat brain monitored by Cellvizio 
Lab System. DHEAS antibody (IgG isotype antibodies) was fluorescently conjugated by an amine-reactive compound, Alexa Fluor 5-
SDP ester 488 dye. The resultant Alexa Fluor 488-conjugated antibodies were collected and analyzed by UV-Vis spectrophotometer 
instrument. The absorbance of the protein-dye conjugate at 280 nm and 494 nm were measured. Then, the degree of labeling (DOL) was 
calculated to achieve the desired results. Fluorescence labelling were carried out into the CA1 region of hippocampus Sprague-Dawley 
rat. We reported that the conjugation was successful. Optimal labeling depending on degree of labeling (DOL) needs some necessity to 
achieve and effective binding to the target neurosteroid, DHEAS. Cellvizio Lab system connected with Fiber Fluorescence Microscopy 
(FFM) probe is presented as a new approach in real-time imaging of DHEAS. In conclusion, we have developed a new method of 
DHEAS-Alexa Fluor fluorescence labelling to visualize and evaluate the changes of DHEAS fluorescence level in the rat hippocampus. 
This novel approach as a diagnostic tool and can be used to better understand the mechanisms and functions of DHEAS and other 
neurosteroids in future research. 
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INTRODUCTION 
 
Dehydroepiandrosterone sulphate (DHEAS) is a steroid 
which naturally synthesized in the brain. The steroids 
that are synthesized in the nervous system have been 
termed ‘neurosteroids’ (Baulieu, 1981). Baulieu & 
Robel (1998), reported that concentrations of DHEAS 
are much higher in the brain than in plasma. The 
DHEAS can enhanced short term and long term memory 
performances in a variety of learning tasks.  
Treatment aged animals with DHEAS enhance 
learning and memory in the T-maze footshock 
avoidance apparatus (Farr et al., 2004). Some studies 
have demonstrated that DHEAS enhancing memory 
performances in aged animals (Michael et al., 2001; 
Vallée et al., 2001). Behavior experiments that use the 
Morris water maze, Y maze, and radial arm water maze 
in animal models of learning and memory showed that 
DHEAS supplementation significantly affect 
behavioural performance (Bodensteiner et al., 2008). 
Another study in ovariectomized rats, i.c.v. implants by 
DHEAS may decrease escape latencies and distances to 
platform in the Morris water maze (Frye & Sturgis, 
1995).  
In a study that assessed of learning and memory, 
fluorescence labelling was develop to conjugate between 
DHEAS monoclonal antibodies and Alexa Fluor 5-SDP 
ester 488 dye. Thus, a sulphodichlorophenyl ester (SDP) 
functional group is attached to a fluorophore core, Alexa 
Fluor 488 dye and bind specificity with monoclonal 
antibodies directly to form fluorophore-antibody 
conjugates. Moreover, SDP ester indicated 
hydrolytically stable form of the Alexa Fluor 488 dye 
for amine-conjugations (Molecular Probes, 2007). Vira 
and co-reseachers (2010) reported that the steric 
hindrance and the absence of additional reactive sites on 
the fluorophore may affect the conjugation reaction.  
Conjugation between Alexa Fluor dye and antibodies 
were given exceptionally bright and most photostable 
(Panchuk-Voloshina et al., 1999). In fluorescence 
labelling, achieveing an optimal degree of labeling 
(DOL) and minimizing fluorescence quenching are the 
keys for conjugation (Berlier et al., 2003). Conjugation 
at high molar ratios of the fluorophore toward antibodies 
may cause DOLs become high. Therefore, it can be 
principal to the fluorescence quenching and assume to 
dye-dye interactions (Randolph & Waggoner, 1997). 
The molar coefficient (Ɛdye) of the Alexa Fluor 488 dye 
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is 71,000 and indicated DOLs between ranges 4 to 9. 
Further, at high DOLs, the Alexa Fluor 488 dye undergo 
more resistant to fluorescence quenching.  
The stability to pH of Alexa Fluor dye was 
monitored by measuring their absorption spectra in 
buffers at pH 4-9. The most stable conjugates were 
performed at pH 8.3. For labelling, Alexa Fluor 488 dye 
can be retained the intensity in conjugation with 
antibodies. In principle, any fluorescent dye can be 
chosen to conjugate protein for live cell imaging, and 
many new dyes with improved photochemical properties 
have been developed (Panchuk-Voloshina et al. 1999). 
To complement a develop method of fluorescence 
labelling, Cellvizio Lab system connected with FFM 
probe will be used as an imaging approach to visualize 
and quantify the fluorescence intensity in vivo and real 
time imaging.  
The Cellvizio Lab system provides to visualize deep 
brain through fluorescence imaging, high resolution, 
rapid, in real time image, with minimally invasive, and 
one animal at one time. Besides, stereotaxis apparatus as 
a platform to position the Fiber Fluorescence 
Microscopy (FFM) probe to the exact coordinate of 
target location (Visualsonics, 2009). The probe, an 
approach that designed for cannula implantation on 
anaesthetized animals, consisting of a diameter tip 0.30 
mm, lateral resolution 3.3 µm, optical sectioning 15 µm, 
and maximum field of view 600x500 µm (Vincent et al., 
2006). Therefore, to understand how the brain activity of 
rats achieving in behavioral tasks, the Cellvizio Lab 
system with flexible FFM probe used to record in vivo 
imaging attached with DHEAS-Alexa Fluor 
fluorescence labelling at the region of interest.  
In this article, we report the successful of DHEAS-
Alexa Fluor 488 was expressed in the CA1 region of 
hippocampus rat brain. Here, our goal was to highlight a 
new method of DHEAS-Alexa Fluor 488 as a 
fluorescence labelling of DHEAS and expressed the 
signal of DHEAS by FFM connected with Cellvizio Lab 
system in visualizing real time imaged, hence as a new 
imaging approach based on fluorescence. 
 
 
 
MATERIALS AND METHODS 
 
Antibody and reagents preparation 
DHEAS monoclonal antibodies (3 mg/mL) were bought 
from CalBioreagents. Alexa Fluor SDP Ester labeling 
dye (Thermo Scientific) was used to conjugate with 
antibodies. The corresponding fluorophore: protein (F:P) 
ratio, based on A280 and A494 absorption readings, was 
calculated according to the labeling instructions 
including the recommended correction factors for the 
absorbance of the dye at 280 nm.  
 
 
Evaluation of dye delivery approaches in CA1 region 
of hippocampus 
All procedures were approved by the Animal Ethics 
Committee Universiti Sains Malaysia and followed the 
guidelines of the Animal Research and Service Centre. 
One group (n=7) male Sprague-Dawley (SD) rats (250- 
300 g) anaesthetised with isoflurane. SD rats were 
housed in groups of two per cage with twelve-hour 
light/dark cycle and food and water was provided ad 
libitum. All surgeries were performed under isoflurane 
anaesthesia. Anaesthesia was maintained by mask 
inhalation of isoflurane vaporized at concentrations of 
up 4% in the induction phase, at 2.5% during surgical 
procedures and at 1.0-1.5% during prolonged 
experimental observations. DHEAS, neurosteroid in the 
brain were imaged by using a beveled tip FFM probe 
through a hole in the skull.  The probe was positioned by 
using the holder of motorized stereotaxis device. One 
microliter of DHEAS-Alexa Fluor 488 dye was carried 
out into the CA1 region using 10 µL Hamilton syringe, 
set to eject 1.00 µL over about 10 min. Injection 
coordinates were (in mm): for the CA1 hippocampus, 
AP: -3.00 mm, ML: -1.7 mm and DV: 3.00 mm. Optical 
recording started 1 h later.   
 
Preparation of Alexa Fluor 5-SDP ester 488 dye 
labelled monoclonal antibodies 
Dehydroepiandrosterone sulphate (DHEAS) was 
fluorescently conjugated to an amine-reactive 
compound, Alexa Fluor 5-SDP ester 488 dye 
(Invitrogen). DHEAS solution (3.0 mg/mL) was 
exchanged to sodium bicarbonate by dialysis with 
against 0.1 M sodium bicarbonate solution (pH 8-9) for 
2 hours at room temperature. Then, Alexa Fluor 488 dye 
were prepared in DMF solution at concentration 10 
mg/mL. Therefore, 1.2 µL reactive dye was added into 
the 100 µg DHEAS solution and incubate the solution 
for 1 hour at room temperature. The resultant solution 
was transferred into the membrane dialysis tube and 
dialyzed against PBS (pH 7.4) an overnight in 4oC with 
continuous stirring. The resultant DHEAS-Alexa Fluor 
488 was collected and sterilized via 200 nm polymer 
membrane filter and was stored at 4oC and -20oC for 
long storage. 
The concentration of DHEAS antibodies and Alexa 
Fluor dye were calculated from the absorbance at 280 
and 488 nm, measured using an ultraviolet (UV-Vis) 
spectrophotometer, using the following formula: 
 
The concentration of protein in the sample: 
 
Protein concentration (M) =  
[A280 –  (Adye x CF280)] x dilution factor
203,000
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The degree of labeling: 
 
Moles dye per mole protein = 
Adye x dilution factor
Ɛdye x protein concentration (M)
 (Molecular Probe, 2011) 
 
Real time imaging by Fiber Fluorescence Microscopy 
(FFM) probe connected with Cellvizio Lab system 
After labelling, rats were anaesthetised and positioned 
on a stereotaxis apparatus. The FFM probe with a holder 
was placed into the mount of the stereotaxis device. The 
probe was fixed into position on top of the cannula 
implantation and set the coordinate as bregma point 
(0,0,0). Next, the FFM probe connected with Cellvizio 
Lab system (Le Goualher et al., 2004; Davenne et al., 
2005) and a frame rate was at 12 Hz. Excitation of cells 
at 488 nm laser light and emission was measured at 494 
nm. The Cellvizio Lab system have a single-pixel 
avalanche photodiode detector (APD) for resolution and 
sensitivity, respectively.  
 
 
RESULTS 
 
Development of DHEAS-Alexa Fluor 488 
fluorescence labelling 
We conjugated DHEAS antibody with reactive dye, 
excitation and emission wavelength at 488 nm and 494 
nm, respectively. For this purpose, we determined by 
measuring the optimal degree of labeling with different 
concentration of protein, wherein the buffer pH was 
constant. Table 1 show the absorbance of DHEAS 
antibody and reactive dye based on A280 and A494 
absorption reading, the concentration of protein, dilution 
factor, degree of labeling, and molar coefficient of 
specific dye and correction factor for the fluorophore 
contribution as constant variables. Based the result, the 
absorption reading for antibody and dye increase, the 
degree of labeling of fluorescence intensity was 
increased. Therefore, according to obtained result, 
concentration of antibody, 0.91 M and degree of 
labeling, 4.63 was chosen for this present study as a new 
method.   
 
Table 1. The protein concentration and degree of labeling in different 
protocols. 
 
B
a
tc
h
 
A280 A494 [P] 
D
O
L
 
dl Ɛdye CF280 λmax Em 
1 0.82836 0.57950 0.57 2.17 1 71,000 0.11 494 519 
1 1.64540 0.92632 1.14 1.70 1     
2 1.18320 1.44100 1.51 4.02 2 *constant variables 
3 1.45050 1.99340 0.91 4.63 1 
 
* A280 and A494 is an absorption reading by UV-Vis spectroscopy. 
* [P] is protein concentration in mg/mL. 
* DOL is degree of labeling. 
* dl is dilution factor to modify the calculation. 
* Ɛdye is molar extinction coefficient at λmax in cm-1 M-1. 
* CF280 is correction factor for absorption readings at 280 nm. 
* λmax and Em are the fluorescence absorbance and emission maxima, in nm, 
conjugated to an IgG antibody. 
Conjugation of DHEAS-Alexa Fluor 488 as 
fluorescence labelling 
A standardized protocol was implemented in this 
experiment, and yield less than 4 of DOLs of 
conjugation DHEAS-Alexa Fluor 488. The experimental 
workflow has made some modification and introduced 
two principals in a new method. First, the time 
incubation need to be longer for conjugation. The 
conjugates were incubated overnight to increase 
chemically binding of the DHEAS-Alexa Fluor 
conjugation. To achieve effective labelling, Marks et al. 
(2004) reported that it required the incubation of 1 µM 
5’-Fluorescein-SLF’ for 16 hours. The second 
modification was increased the volume of the dye from 
stock solution against antibody to enhance the 
expression signal of DHEAS-Alexa Fluor fluorescence 
intensity. The standard protocol of dye was 1.2 µL dye 
in 100 µg antibody (10 mg/mL). Therefore, in this study 
the method was modified, 2.4 µL dye in 100 µg 
antibody. The UV spectra for batch 2 and 3 has shown 
in figure 1.  
 
 
 
 
 
Figure 1. The UV spectra showing the absorption DHEAS antibody and 
Alexa Fluor dye for batch 1, batch 2 and batch 3. The absorption peaks at 
288 nm and 494 nm correspond to the absorption for antibody and 
excitation of Alexa Fluor 488 dye, respectively. 
 
 
Expression of DHEAS-Alexa Fluor fluorescence 
labelling by FFM Imaging 
FFM probe attached to Cellvizio Lab system has been 
used to monitor DHEAS fluorescence levels in the 
hippocampal CA1 region. The characteristics of 
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microprobe S300B was shown in Table 2. Sprague-
Dawley rat was positioned and placement on the 
motorized stereotaxis apparatus, then DHEAS-Alexa 
Fluor 488 fluorescence labelling was carried out into the 
CA1 region of hippocampus of anaesthetized animals. 
One hour after labelling, FFM imaging was visualized 
and imaged the signal of DHEAS fluorescence 
expression. The changes of DHEAS fluorescence 
expression was quantified and recorded the images at 
region of interest (ROI)s in real time imaged and 
minimally invasiveness.   
 
Table 2. Properties of the microprobe S-300B used in this study. 
 
Probe S-300B 
Diameter (mm) 0.30 
Maximum field of view (µm x µm) 600 x 500 
Axial resolution (µm) 15 
Lateral resolution (µm) 3.3 
* Values provided by Cellvizio Lab system, Mauna Kea Technologies, 
France 
 
 
 
 
 
 
Figure 2. The signal of DHEAS fluorescence expression. (A) The images 
visualized indicated the DHEAS fluorescence was expressed the signal in 
hippocampal CA1 region. (B) The region of interest (ROI) of DHEAS 
fluorescence signal were selected.  
 
 
DISCUSSION 
 
The excitation and emission spectra of Alexa Fluor 488 
dye are illustrated in Figure 3. Figure 1 in this present 
study demonstrated the UV-Vis spectra of Alexa Fluor 
5-SDP ester 488 dye conjugated with DHEAS 
antibodies. The UV-Vis spectrophotometer is a useful 
instrument in most laboratories (Shahal et al., 2016). 
The aim of this study was to develop method of 
DHEAS-Alexa Fluor fluorescence labelling and evaluate 
the successful conjugation to be used as a tagging for 
DHEAS in the CA1 region of hippocampus by imaging 
approach, FFM connected with Cellvizio Lab system. 
This finding indicated that the antibody conjugation was 
effectively and efficiently to be used as fluorescence 
labelling to image and quantify DHEAS in the 
hippocampus rat brain by FFM imaging. 
 
 
 
Figure 3. The illustration of excitation and emission spectra of Alexa 
Fluor 488 dye. 
 
Coons and co-researchers (1950) showed that 
antibody conjugation widely uses nowadays in the 
biological sciences and medicine. In conjunction, 
labelling method is a direct technique which is the 
antibodies chemically conjugated to a fluorescent dye. 
The result of this study indicated that conjugation 
between Alexa Fluor 488 dye and DHEAS antibodies 
was succeed. The result of the present study also suggest 
that based on calculation degree of labeling, the F:P 
ratio the conjugation should be in range 4 to 9 (Table 1). 
This finding indicated that fluorescence labelling can be 
effective used and given brighter expression in animal 
studies (Hayashi-Takanaka et al., 2014; Vira et al., 
2010). 
In order to obtain better labelling, the parameters that 
can affected the fluorescence should be considered. 
Firstly, the antibodies and reactive dye should be in the 
same buffer. In this case, 0.1 M sodium bicarbonate was 
used to change the buffer of antibodies. It is necessary to 
achieve strongly binding in the covalent bond of 
conjugation. Furthermore, longer incubation time 
required for fluorescence labelling protocols to 
determine the optimal DOL of DHEAS-Alexa Fluor 488 
conjugates. This suggested that the conjugation leaves 
for an overnight or at least 16 hours to increase the 
fluorescence intensity. The absorption data from UV-Vis 
spectra was increased corresponding to the time of 
incubation. Additionally, we modified the approach of 
  
 
 Shaimi et al. – Novel Approaches for Detection Fluorescent-Labeled … 5 
 
 
the dye from standard labeling protocols to increase the 
efficiency of labeling. Initial experiment was conducted 
with preparation dye in standard protocol (1.2 µL dye in 
100 µg antibody). We altered the dye which is increase 
the volume of dye from stock solution into twice time, 
2.4 µL dye in 100 µg antibody. The results in this 
present study demonstrated that increased the DOL of 
conjugation.  
There are have several requirements were 
highlighted in order to achieve the better labelling. This 
could be due these findings accordance with the 
previous studies and clearly demonstrated of brightness, 
photostability, photobleaching, binding affinity, size of 
fluorophore, fluorescent lifetime and molar coefficient 
(Hayashi-Takanaka et al., 2014; Shaner et al., 2005; 
Toseland, 2013). Additionally, better expression of 
fluorescent labelling influence by pH sensitivity (Shaner 
et al., 2005). Thus, pH conditions performed as an 
indicator of fluorescent lifetime in conjugation of 
imaging living cells (Lin et al., 2003).  
The FFM probe was inserted into the brain to 
recorded and quantified the changes of DHEAS 
fluorescence intensity level in the CA1 region of 
hippocampus. Surprisingly, this present study is the first 
report to evaluate the expression of DHEAS 
fluorescence in the target area, CA1 area of 
hippocampus by FFM connected with Cellvizio Lab 
system. According to Vincent et al. (2006) demonstrated 
that Cellvizio Lab system allowed researchers to 
visualize calcium signals in deep brain structures. These 
results are consistent with FFM connected with 
Cellvizio Lab system that allowed the direct recording in 
a short time frame, same animals can be used repeatedly, 
avoiding shrinkage of cells and tissues, and flexible 
probes (Frykman et al. 1988). Thus, FFM connected 
with Cellvizio Lab system was essential for in vivo 
imaging associated with behavioral task in order to time 
saving and does not require sample preparation or 
staining to prove the presence of fluorescence labelling.   
In this present study showed the signal of DHEAS 
fluorescence expressed at the region of interest (Figure 
2). This finding indicate that the signal of expression 
DHEAS fluorescence can be used as a potential in vivo 
imaging to evaluate and quantify the changes of DHEAS 
level in the rat brain due to physiology, pathology and 
pharmacology process (Vincent et al., 2006; 
Visualsonics, 2009). Accordingly, the results in this 
study presumed that the changes of DHEAS 
fluorescence expression associated with cognition. We 
have developed new method of fluorescence labelling in 
conjunction with fluorescence imaging approach, FFM 
connected with Cellvizio Lab system that precise and 
accurate visualization of fluorescence signals in living 
brains as well as non-invasive method for cellular level 
imaging in vivo (Davenne et al., 2005; Vincent et al., 
2006; Makhlouf et al., 2008). 
 
 
CONCLUSION 
 
In conclusion, DHEAS-Alexa Fluor 488 fluorescence 
labelling was developed to monitor and evaluate the 
changes of DHEAS fluorescence level that expressed in 
the CA1 region of hippocampus. Beyond imaging, the 
DHEAS-Alexa Fluor fluorescence labelling is one step 
approach to monitor dynamic behavioral task and better 
understand the mechanisms of DHEAS. Moreover, this 
approach can be used to discover the beneficial 
functions of DHEAS and other neurosteroids in the 
hippocampus at preclinical level to encourage in future 
research.  
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